Clinical Outcomes After Viremia Among People Receiving Dolutegravir vs Efavirenz-Based First-line Antiretroviral Therapy in South Africa.

Kwabena Asare Lara LewisJohan van der MolenYukteshwar SookrajhThokozani KhubonePravikrishnen MoodleyRichard J Lessells Kogieleum NaidooPhelelani SosiboSharana Mahomed Jienchi Dorward

Published in: Open forum infectious diseases (2023)

Among people with viremia on first-line ART, dolutegravir was associated with slightly better retention in care and similar or better viral suppression than efavirenz.

Keyphrases

antiretroviral therapy
hiv positive
hiv infected
hiv infected patients
south africa
human immunodeficiency virus
hiv aids
healthcare
palliative care
sars cov
quality improvement
pain management
chronic pain